Underused options for preventing and treating influenza

Sherif B. Mossad, MD
Department of Infectious Diseases, Cleveland Clinic

Address: Sherif B. Mossad, MD, Department of Infectious Diseases, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195-5066, mossads@ccf.org

Dr. Mossad is the principal investigator in a study funded by Immunex Corporation, testing the possible adjuvant effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on influenza vaccine in bone marrow transplant and heart transplant recipients.

Sherif B. Mossad, MD
Department of Infectious Diseases, Cleveland Clinic

Address: Sherif B. Mossad, MD, Department of Infectious Diseases, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195-5066, mossads@ccf.org

Dr. Mossad is the principal investigator in a study funded by Immunex Corporation, testing the possible adjuvant effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on influenza vaccine in bone marrow transplant and heart transplant recipients.

Sherif B. Mossad, MD
Department of Infectious Diseases, Cleveland Clinic

Address: Sherif B. Mossad, MD, Department of Infectious Diseases, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195-5066, mossads@ccf.org

Dr. Mossad is the principal investigator in a study funded by Immunex Corporation, testing the possible adjuvant effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on influenza vaccine in bone marrow transplant and heart transplant recipients.